Allergens, Allergy Testing, and Allergy Therapeutics
2022 AAAAI Annual Meeting - Virtual Content Available
The 2022 AAAAI Annual Meeting is available for virtual participation through December 31, 2022. Visit the Annual Meeting website to register and access the virtual content.
Sessions on Allergens, Allergy Testing, and Allergy Therapeutics include:
1205 Diagnostics in Allergy & Immunology: An Update
1806 Controversial Topics in Allergen Immunotherapy: Dose Adjustment Strategies after Gaps in Therapy, Severe Asthma, Waiting Times and Epinephrine Autoinjectors
2101 Preparing for the Next Pandemic: From Mechanisms to Vaccines
2307 Allergen Immunotherapy (AIT): New Forms and New Data on Old Variants
2522 National Institute of Environmental Health Sciences (NIEHS): Molecular Characterization of Allergens and Specific IgE Antibodies
2553 Patients with Severe Asthma Should Be Permitted to Receive Allergen Immunotherapy
2809 Subcutaneous Immunotherapy: Cross-Reactivity, Extract Stability and Optimum Dosing
2811 Allergic Disease Triggered by Cannabis Production and Consumption
3704 EORD: Impact of Climate Change on Pollen, Mold and Susceptibility to COVID-19 Infection
5125 Personalized Medicine and Rhinitis
5126 Allergen Diagnostics: Component Testing for Respiratory Allergens
5127 Diagnosis in Allergic Respiratory Diseases: Beyond Detection of Immunoglobulin E (IgE)
5134 Allied Health: Research Studies and Oral Immunotherapy (OIT): One Size Does Not Fit All
5144 COVID-19 and Allergen Immunotherapy
5209 Dynamic Interactions of Pollen and the Environment with Allergic and Respiratory Disease
Allergens, Allergy Testing, and Allergy Therapeutics Resources for Healthcare Providers
Allergy Skin Test and Immunotherapy Forms
Compounding Corner: Resources for USP Chapter 797 Standards for Physician In-Office Compounding of Allergen Extracts
Consultation and Referral Guidelines
AAAAI Statements and Practice Parameters reflect the most current guidance available from the AAAAI on clinical topics related to allergies, asthma and immunologic disease.
Allergens, Allergy Testing, and Allergy Therapeutics Resources include an overview, explanation of symptoms and diagnosis, treatment and management, an action plan, information for patients, and more.
Collaborate with Allergy Professionals
Interested in collaborating with fellow AAAAI members who share a particular interest in Allergy Education? The IRSO Interest Section is the community for AAAAI members interested in focusing and networking on the pathogenesis, prevalence, diagnosis and management of rhinitis, sinusitis and hypersensitivity ocular disorders. Topics covered include: allergy diagnostics and standardization, immunotherapy, diagnosis and treatment of rhinitis, sinusitis and ophthalmic conditions secondary to allergy.
To learn more about the work of this interest section, contact one of the leaders below:
Chair: Patricia Takach MD FAAAAI
Vice Chair: Christopher W. Calabria, MD FAAAAI
Secretary: Tolly Epstein, MD MS FAAAAI
Staff Liaison: Nicole Brinkley
Interested in aligning with IRSO?
Becoming part of the IRSO community network is as simple as linking to your AAAAI personal member profiles and updating your profile to reflect your primary membership as IRSO under the tab labeled Involvement.
Or, consider the work of the Immunotherapy, Allergen Standardization and Allergy Diagnostics Committee. Its purpose is to promote education concerning the diagnosis, assessment and treatment of allergies. NOTE: Interest Section Committees are open to all members of the AAAAI.